Last updated: February 14, 2026
Overview of the Drug
NDC 49230-0645 is marketed as a prescription medication, likely used for [indication], with specific formulation and dosage details. The drug’s approval history, therapeutic class, and competitive landscape influence its market dynamics.
Regulatory and Patent Status
- Approval: FDA approval was granted on [date], with continued post-marketing surveillance.
- Patents: Patent protection expires on [date], enabling potential generic entry.
- Orphan Drug Status: Not applicable, which affects exclusivity and market entry timelines.
Therapeutic Market Context
The drug operates within the [therapeutic class], which encompasses approximately [number] similar products. The market size for this class is estimated at $X billion globally, with approximately Y million patients affected.
Market Dynamics
- Current Market Size: Estimated at $X million in the U.S. for 2023.
- Market Growth: Projected compound annual growth rate (CAGR) of Z% over the next 5 years.
- Key Players: Competing drugs include [Drug A], [Drug B], and biosimilars, if applicable.
- Market Share: The primary brand holds roughly X%; generics constitute Y%.
Pricing Trends
- Current Average Wholesale Price (AWP): Approximately $X per unit.
- Retail Price Range: From $Y to $Z depending on dosage and packaging.
- Reimbursement Landscape: Predominantly covered by Medicare, Medicaid, and private insurers. Reimbursement rates influence net sales and price stability.
Price Projections (Next 5 Years)
| Year |
Estimated AWP |
Market Volume |
Estimated Revenue |
Notes |
| 2023 |
$X |
Y million units |
$Z million |
Current pricing trend |
| 2024 |
$X+2% |
+3% |
+$Z+Y% |
Anticipated competitive pressure |
| 2025 |
$X+4% |
+2% |
+$Z+Y% |
Potential generic entry |
| 2026 |
$X+6% |
+1% |
+$Z+Y% |
Market stabilization |
| 2027 |
$X+8% |
+1% |
+$Z+Y% |
Price normalization |
Predicted price increments are based on historical trends, inflation, and anticipated market competition.
Competitive and Market Entry Considerations
- Biosimilars and Generics: Entry post-patent expiry could reduce prices by 20–50%.
- Negotiation Power: Insurers’ negotiations could cap prices, especially in Medicaid and Medicare.
- Manufacturing Trends: Cost reductions in production may enable price stabilization or reductions.
Potential Impact Factors
- Risk of patent challenges.
- Regulatory delays affecting market entry.
- Changes in health policy or reimbursement schemes.
- Development of alternative therapies or combination drugs.
Key Takeaways
- Market size for the drug remains stable with slow growth driven by increased adoption.
- Price increases are likely to be modest (2–8%) annually, contingent on patent and regulatory status.
- Generic entry post-202x can lead to significant price competition.
- Reimbursement patterns heavily influence net revenues, particularly with insurer negotiations.
FAQs
1. How does patent expiration influence the drug’s market price?
Patent expiration opens the market to generics, typically reducing prices by 20% to 50%.
2. What factors are most likely to impact pricing in the next five years?
Generic competition, regulatory changes, and insurer negotiations.
3. How significant is the role of biosimilars if applicable?
Biosimilars can substantially lower prices in biologic markets, increasing competition and reducing revenue for the originator.
4. What is the current market size for this category?
The global market is approximately $X billion, with the U.S. accounting for about Y% of that.
5. How do reimbursement and payer strategies influence market prices?
Insurers negotiate discounts and formulary placements that impact net drug prices considerably.
References
- [1] Market data from IQVIA, 2023.
- [2] FDA drug approval database, 2023.
- [3] Medicare reimbursement policies, CMS, 2023.
- [4] Industry reports from EvaluatePharma, 2023.
- [5] Patent expiry dates and generic entry forecasts, Uriach, 2022.
